THERAPY-RELATED MYELOID NEOPLASMS IN PATIENTS TREATED FOR HODGKIN LYMPHOMA
Hodgkin lymphoma (HL) is a malignancy of the lymphatic system with an incidence of 2-3/100.000/year in developed countries. With modern multi-agent chemotherapy protocols optionally combined with radiotherapy (RT), 80% to 90% of HL patients achieve long-term remission and can be considered cured. Ho...
Saved in:
Main Authors: | Dennis A Eichenauer, Andreas Engert |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2011-10-01
|
Series: | Mediterranean Journal of Hematology and Infectious Diseases |
Online Access: | http://www.mjhid.org/index.php/mjhid/article/view/290 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
by: Raffaella Marcheselli, et al.
Published: (2011-01-01) -
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
by: Alessia Bari, et al.
Published: (2011-12-01) -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION.
by: Raffaele Palmieri, et al.
Published: (2023-08-01) -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
by: Rachel Bergerson, et al.
Published: (2011-01-01) -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
by: Angela Stoddart, et al.
Published: (2011-05-01)